Clinical Trials Directory

Trials / Completed

CompletedNCT02566187

A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
99 (actual)
Sponsor
Boryung Pharmaceutical Co., Ltd · Industry
Sex
Male
Age
19 Years – 50 Years
Healthy volunteers
Accepted

Summary

A phase I, Open-label, Randomized, Single-dose, 2 x 2 Crossover Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet and Coadministration of Fimasartan and Atorvastatin as Individual Tablets in Healthy Male Volunteers.

Conditions

Interventions

TypeNameDescription
DRUGFimasartan/Atorvastatin Combination Tablet
DRUGFimasartan
DRUGAtorvastatin

Timeline

Start date
2015-08-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2015-10-02
Last updated
2016-02-25

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02566187. Inclusion in this directory is not an endorsement.

A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet (NCT02566187) · Clinical Trials Directory